Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3038 |
|
Actual shortage: | 231 (8%) | |
Anticipated shortage: | 14 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2784 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (12%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-PRAMIPEXOLE | 0.5MG | TABLET | Resolved | 2018-11-09 | 2019-01-12 | 66540 |
APO-IRBESARTAN | 75MG | TABLET | Actual shortage | 2018-11-09 | 2018-11-09 | 66534 |
APO-PRAVASTATIN | 40MG | TABLET | Resolved | 2018-10-25 | 2018-11-22 | 65602 |
APO-METHYLPHENIDATE ER | 18MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-10-25 | 2018-11-22 | 65599 |
APO-ENALAPRIL | 5MG | TABLET | Resolved | 2018-10-25 | 2018-12-08 | 65595 |
APO-DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | Resolved | 2018-10-25 | 2018-11-20 | 65592 |
APO-ARIPIPRAZOLE | 2MG | TABLET | Resolved | 2018-10-25 | 2018-11-26 | 65588 |
APO-TERAZOSIN | 2MG | TABLET | Resolved | 2018-10-19 | 2018-12-27 | 65008 |
APO-VALACYCLOVIR | 500MG | TABLET | Resolved | 2018-10-19 | 2018-11-22 | 65005 |
APO-SILDENAFIL | 50MG | TABLET | Resolved | 2018-10-19 | 2019-01-03 | 64996 |
APO-RISEDRONATE | 35MG | TABLET | Resolved | 2018-10-19 | 2018-12-21 | 64981 |
APO-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2018-10-19 | 2019-02-06 | 64956 |
APO-LEVETIRACETAM | 250MG | TABLET | Resolved | 2018-10-19 | 2019-01-10 | 64938 |
APO-DOXYLAMINE/B6 | 10MG 10MG | TABLET (DELAYED-RELEASE) | Resolved | 2018-10-19 | 2019-05-03 | 64934 |
APO-TRYPTOPHAN | 500MG | TABLET | Resolved | 2018-10-11 | 2018-11-22 | 63807 |
APO-SIMVASTATIN | 5MG | TABLET | Resolved | 2018-10-11 | 2018-11-02 | 63803 |
APO-PERINDOPRIL | 8MG | TABLET | Resolved | 2018-10-11 | 2018-11-22 | 63800 |
APO-MYCOPHENOLATE | 250MG | CAPSULE | Resolved | 2018-10-11 | 2019-06-08 | 63796 |
APO-MONTELUKAST | 5MG | TABLET (CHEWABLE) | Resolved | 2018-10-11 | 2018-10-16 | 63793 |
APO-TERAZOSIN | 10MG | TABLET | Resolved | 2018-10-02 | 2018-12-27 | 62871 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-DICLO SR | 75MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2017-03-31 | 2017-03-31 | 4915 |
APO-DICLO SR | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2017-03-31 | 2017-03-31 | 4909 |
APO-AMOXI CLAV 250MG/62.5MG PER 5ML | 250MG 62.5MG | POWDER FOR SUSPENSION | Discontinued | 2017-03-31 | 2017-03-31 | 4906 |
APO-AMOXI CLAV 125MG/31.25MG PER 5ML | 125MG 31.25MG | POWDER FOR SUSPENSION | Discontinued | 2017-03-31 | 2017-03-31 | 4903 |
APO-TERAZOSIN | 5MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4749 |
APO-TERAZOSIN | 1MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4745 |
APO-OLANZAPINE | 2.5MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4738 |
APO-NAPROXEN | 250MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4734 |
APO-FUROSEMIDE | 80MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4719 |
APO-FLUVOXAMINE | 50MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4716 |
APO-FLUVOXAMINE | 100MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4713 |
APO-DOXY TABS 100MG | 100MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4707 |
APO CHLORPROPAMIDE TAB 250MG | 250 mg | tablet | Discontinued | 2017-03-13 | 2018-02-05 | 1235 |
APO CHLORPROPAMIDE TAB 100MG | 100MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1196 |
APO-SULIN TAB 150MG | 150mg | tablet | Discontinued | 2017-03-13 | 2017-03-13 | 1186 |
APO-SULIN TAB 200MG | 200MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1172 |
APO-PROPRANOLOL | 20MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1163 |
APO-NORTRIPTYLINE | 25MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1155 |
APO-NORTRIPTYLINE | 10MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1145 |
APO-NIZATIDINE | 300MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1135 |